Eosinophils and respiratory virus infection: A dual-standard curve qRT-PCR-based method for determining virus recovery from mouse lung tissue

Methods in Molecular Biology

Volumn 1178, Issue , 2014, Pages 257-266

  Percopo, Caroline M ^a   Dyer, Kimberly D ^a   Karpe, Kendal A ^a   Domachowske, Joseph B ^b   Rosenberg, Helene F ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Eosinophil; Inflammation; Leukocyte; Pneumonia virus of mice; Polymerase chain reaction

Indexed keywords

CYTOKINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EOSINOPHIL; HOST RESISTANCE; LUNG HOMOGENATE; LUNG PARENCHYMA; MEASUREMENT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNTHESIS; TISSUE CULTURE; VIRUS INFECTIVITY; VIRUS PNEUMONIA; ANIMAL; CYTOLOGY; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY;

ANIMALS; EOSINOPHILS; LUNG; MICE; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 84924503537     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1016-8_22     Document Type: Article

References (16)

1. Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL (2012) The microbiology of asthma. Nat Rev Microbiol 10: 459-471
2. Gibson PG (2009) inflammatory phenotypes in adult asthma: Clinical applications. Clin Respir J 3:198-206
3. Lin TY, Poon AH, Hamid Q (2013) Asthma phenotypes and endotypes. Curr Opin Pulm Med 19:18-23
4. Walsh GM (2013) Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma. Biologics 7:7-11
5. Castro M, Mathur S, Hargreave F, Boulet LP, Xie F, Young J, Wilkins HJ, Henkel T, Nair P, Res-5-0010 Study Group (2010) Reslizumab for poorly controlled, eosinophilic asthma: A randomized, placebo controlled study. Am J Respir Crit Care Med 184:1125-1132
6. Thomas A, Busse W (2012) The evolving role of eosinophils in asthma. In: Lee JJ, Rosenberg HF (eds) Eosinophils in health and disease. Elsevier, Inc., Waltham, MA, pp 448-461
7. Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: Changing perspectives in health and disease. Nat Rev Immunol 13:9-22
8. Domachowske JB, Dyer KD, Bonville CA, Rosenberg HF (1998) Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis 177: 1458-1464
9. Adamko DJ, Yost BL, Gleich GJ, Fryer AD, Jacoby DB (1999) Ovalbumin sensitization changes the inflammatory response to subsequent parainfl uenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction and antiviral effects. J Exp Med 190:1465-1478
10. Phipps S, Lam CE, Mahalingam S, Newhouse M, Ramirez R, Rosenberg HF, Foster PS, Matthaei KI (2007) Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 110:1578-1586
11. Percopo CM, Dyer KD, Ochkur SI, Luo JL, Fischer ER, Lee JJ, Lee NA, Domachowske JB, Rosenberg HF (2014) Activated mouse eosinophils protect against lethal respiratory virus infection. Blood. 123:743-752
12. Bem RA, Domachowske JB, Rosenberg HF (2011) Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol 301:L148-L156
13. Gabryszewski SJ, Bachar O, Dyer KD, Percopo CM, Killoran KE, Domachowske JB, Rosenberg HF (2011) Lactobacilllus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J Immunol 186:1151-1161
14. Garcia-Crespo KE, Chan CC, Gabryszewski SJ, Percopo CM, Rigaux P, Dyer KD, Domachowske JB, Rosenberg HF (2013) Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection. Antiviral Res 97:270-279
15. Glineur SF, Renshaw RW, Percopo CM, Dyer KD, Dubovi EJ, Domachowske JB, Rosenberg HF (2013) Novel pneumoviruses (PnVs): Evolution and inflammatory pathology. Virology 443:257-264
16. Ochkur SI, Jacobsen EA, Protheroe CA, Biechele TL, Pero RS, McGarry MP, Wang H, O'Neill KR, Colbert DC, Colby TV, Shen H, Blackburn MR, Irvin CC, Lee JJ, Lee NA (2007) Co-expression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J Immunol 178: 7879-7889